Ligne de temps
Rafael Machado
Post-doctorant(e)
24 févr. 2024
publication
Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome.
Lire plus01 févr. 2024
publication
Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future.
Lire plus30 janv. 2024
publication
Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster.
Lire plus17 juil. 2023
publication
Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters.
Lire plus28 févr. 2023
publication
Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests.
Lire plus28 déc. 2022
publication
Primary and Secondary Attack Rates by Vaccination Status after a SARS-CoV-2 B.1.617.2 (Delta) Variant Outbreak at a Youth Summer Camp-Texas, June 2021.
Lire plus18 sept. 2022
publication
Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
Lire plus13 août 2022
publication
Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes.
Lire plus11 août 2022
publication
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease.
Lire plus01 juin 2022
publication
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI).
Lire plus01 mai 2022
publication
A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
Lire plus09 févr. 2022
publication
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection.
Lire plus01 févr. 2022
publication
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
Lire plus01 janv. 2022
publication
Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil.
Lire plus01 janv. 2022
publication
Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.
Lire plus01 janv. 2022
publication
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.
Lire plus23 déc. 2021
publication
Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: Triple-blind clinical trial.
Lire plus01 déc. 2021
publication
Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?
Lire plus08 oct. 2021
publication
Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells.
Lire plus07 oct. 2021
publication
Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial.
Lire plus01 oct. 2021
publication
Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies.
Lire plus28 sept. 2021
publication
Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.
Lire plus01 août 2021
publication
COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.
Lire plus01 mai 2021
publication
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections.
Lire plus01 mai 2021
30 avr. 2021
publication
Neonatal consequences of maternal exposure to the chikungunya virus: Case reports.
Lire plus01 avr. 2021
publication
Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing.
Lire plus01 janv. 2021
publication
Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman Syndrome.
Lire plus01 déc. 2020
publication
Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
Lire plus01 déc. 2020
01 oct. 2020
publication
Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report.
Lire plus01 sept. 2020
publication
Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR.
Lire plus01 janv. 2020
publication
SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network.
Lire plus01 janv. 2020
publication
Alphacoronavirus Detection in Lungs, Liver, and Intestines of Bats from Brazil.
Lire plus01 janv. 2020
publication
Zika virus seroprevalence in blood donors from the Northeastern region of São Paulo State, Brazil, between 2015 and 2017.
Lire plus01 mars 2019
19 janv. 2018
01 janv. 2018
publication